Oruka Therapeutics, Inc.
COMPANY
10-Q
FORM
2025-05-14
FILING DATE
2025-03-31
Q1 PERIOD END
945
FACTS
SIC 2834
Filing Software CompSci
CIK 0000907654
Taxonomy US GAAP 2025  
SIC 2834
CIK 0000907654
Filing Software CompSci
Taxonomy US GAAP 2025  
Standard Concepts
286
Extended Concepts
94
25%
Extended Concepts
Errors
0
What are errors?
What are errors?
Indicate problems with an XBRL formatted filing that are sufficient grounds for SEC rejection of the XBRL portion of the filing.
Data Quality Errors
1
ERROR
The element us-gaap:OperatingLeaseExpense with a value of 62,000 has been reported in the filing but the element OperatingLeaseCost is missing from the filing. Please check that the value for OperatingLeaseCost has not been tagged with another element or is missing from the filing. Period :2025-01-01 to 2025-03-31 Dimensions : Unit : USD Decimals: -3 Rule Element Id:9372 Rule version: 26.0.7
What are data quality errors?
What are data quality errors?
Indicate areas that may not meet the standards set by the Data Quality Committee (DQC), and may reveal areas where the XBRL can be improved.
Possible Issues
1
WARNING
1 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CostsAndExpensesRelatedParty
What are possible issues?
What are possible issues?
Indicate areas of interest as to the quality of an XBRL formatted filing, and in some cases reveal opportunities for improvement of the XBRL filing.
SEC: Filing | Interactive Data